in silico molecular docking studies

Pharmaceutical Chemistry

Molecular docking is a pivotal computational technique in drug design, aimed at predicting the optimal binding orientation of ligands to target proteins. This process not only elucidates protein-ligand interactions but also facilitates virtual screening, which accelerates the identification of lead compounds from extensive chemical libraries. With advances in structural biology, including X-ray crystallography and NMR, the availability of three-dimensional protein structures has enhanced the accuracy of docking simulations. The technique can be classified into rigid and flexible docking, addressing molecular dynamics during binding. Additionally, it encompasses covalent docking methods to assess ligands that form permanent interactions with targets. As molecular modeling evolves, docking approaches continue to integrate machine learning and high-throughput methods, enhancing efficiency in drug discovery. This comprehensive exploration of molecular docking underscores its significance in unraveling complex biological interactions and fostering innovative therapeutic developments.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.